Buy Geftinat - 250 Gefitinib Tab IP

Geftinat - 250 is a gefitinib tablet used for targeted cancer therapy. This 250mg oral medication is prescribed for specific lung cancer types. It belongs to the EGFR inhibitor class and is available in a 30-tablet pack. Store at ambient temperature for stability.

Strength

250mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

NATCO PHARMA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Gefitinib tablet 250mg is primarily used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It works by blocking signals that promote cancer cell growth. This medication is often prescribed when cancer has specific genetic markers. Gefitinib may be used alone or combined with other therapies as directed by a healthcare provider.

Side Effects

Gefitinib tablets may help slow the progression of cancer cells in eligible patients. Common effects include skin reactions, diarrhea, or nausea, which vary by individual. Some users report fatigue or reduced appetite during treatment. These effects are typically monitored by a medical professional throughout therapy.

Precautions & Warnings

Keep gefitinib tablets in their original packaging away from moisture and direct sunlight. Store at room temperature and avoid exposure to extreme heat or cold. Always handle with dry hands and return unused medication to a pharmacy for disposal. Report any persistent side effects to your doctor promptly.

Avoid Interactions

Gefitinib may interact with certain medications, including strong CYP3A4 inhibitors or inducers. Avoid grapefruit products while taking this tablet, as they can affect drug metabolism. Discuss all current prescriptions and supplements with your healthcare provider before starting gefitinib. Alcohol use may intensify side effects like drowsiness.

References

Frequently Asked Questions

Gefitinib 250mg is used to treat specific types of non-small cell lung cancer in adults.

Store gefitinib tablets at room temperature in their original packaging, away from moisture and light.

Consult your doctor before combining gefitinib with other drugs to avoid potential interactions.

Common effects may include skin reactions, diarrhea, nausea, fatigue, or reduced appetite.

No, gefitinib is a prescription medication and requires medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.